TCL Archive CHOP Evolution Remains Touchy Issues; Contractors Say NCI Plan Too Burdensome April 22, 1983
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Cancer Control Contract Negotiations To Start Soon; Two Weaknesses Occur In Many Proposals March 7, 1975